Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance

Abstract In many countries, hormone receptor status assessment of ductal carcinoma in situ (DCIS) is routinely performed, as hormone receptor-positive DCIS patients are eligible for adjuvant anti-hormonal treatment, aiming to reduce the ipsilateral and contralateral breast cancer risk. Although HER2...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Mieke R. Van Bockstal, Jelle Wesseling, Ester H. Lips, Marjolein Smidt, Christine Galant, Carolien H. M. van Deurzen
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2024-08-01
Serie:	Breast Cancer Research
Ämnen:	Ductal carcinoma in situ HER2 Immunohistochemistry Breast Grade Hormone receptor status
Länkar:	https://doi.org/10.1186/s13058-024-01875-w
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!